Hema Parmar

Hema Parmar PhD is an experienced clinical development executive with a strong background in oncology. Currently serving as the Executive Director of Clinical Development at Revolution Medicines, Hema has held key roles at leading pharmaceutical companies, including Senior Director of Oncology Early Clinical Science at Pfizer and Director of Clinical Science at Seagen. Hema also contributed significantly as Senior Director of Clinical Science at both Atara Biotherapeutics and Rakuten Medical, showcasing expertise in advancing clinical research and development in the oncology sector.